Drug Master Files for: mitomycin
✉ Email this page to a colleague
mitomycin Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
13521 | I | II | 9/1/1998 | KYOWA HAKKO KOGYO CO LTD | MITOMYCIN |
13783 | I | II | 9/1/1998 | ZHEJIANG HISUN PHARMACEUTICAL CO LTD | MITOMYCIN USP |
13785 | I | II | 9/1/1998 | MICROBIOPHARM JAPAN CO LTD | MITOMYCIN |
13791 | A | II | 9/1/1998 | TEVA PHARMACEUTICAL INDUSTRIES LTD | MITOMYCIN |
18599 | I | II | 7/14/1988 | BIOLOGICAL THERAPY INSTITUTE | MITOMYCIN-C CONJUGATED MURINE MONOCLONAL ANTIBODIES |
25659 | A | II | 12/30/2011 | ZHEJIANG HISUN PHARMACEUTICAL CO LTD | MITOMYCIN USP (ALTERNATIVE PROCESS) |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information